Cargando…

Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency

BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) is most common among urea cycle disorders (UCDs), defined by defects in enzymes associated with ureagenesis. Corticosteroid administration to UCD patients, including OTCD patients, is suggested to be avoided, as it may induce life-threatening...

Descripción completa

Detalles Bibliográficos
Autores principales: Imoto, Koji, Tanaka, Masatake, Goya, Takeshi, Aoyagi, Tomomi, Takahashi, Motoi, Kurokawa, Miho, Tashiro, Shigeki, Kato, Masaki, Kohjima, Motoyuki, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962007/
https://www.ncbi.nlm.nih.gov/pubmed/35346058
http://dx.doi.org/10.1186/s12876-022-02213-0
_version_ 1784677706677354496
author Imoto, Koji
Tanaka, Masatake
Goya, Takeshi
Aoyagi, Tomomi
Takahashi, Motoi
Kurokawa, Miho
Tashiro, Shigeki
Kato, Masaki
Kohjima, Motoyuki
Ogawa, Yoshihiro
author_facet Imoto, Koji
Tanaka, Masatake
Goya, Takeshi
Aoyagi, Tomomi
Takahashi, Motoi
Kurokawa, Miho
Tashiro, Shigeki
Kato, Masaki
Kohjima, Motoyuki
Ogawa, Yoshihiro
author_sort Imoto, Koji
collection PubMed
description BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) is most common among urea cycle disorders (UCDs), defined by defects in enzymes associated with ureagenesis. Corticosteroid administration to UCD patients, including OTCD patients, is suggested to be avoided, as it may induce life-threatening hyperammonemia. The mechanism has been considered nitrogen overload due to the catabolic effect of corticosteroids; however, the pathophysiological process is unclear. METHODS: To elucidate the mechanism of hyperammonemia induced by corticosteroid administration in OTCD patients, we analyzed a mouse model by administering corticosteroids to OTC(spf−ash) mice deficient in the OTC gene. Dexamethasone (DEX; 20 mg/kg) was administered to the OTC(spf−ash) and wild-type (WT) mice at 0 and 24 h, and the serum ammonia concentrations, the levels of the hepatic metabolites, and the gene expressions related with ammonia metabolism in the livers and muscles were analyzed. RESULTS: The ammonia levels in Otc(spf−ash) mice that were administered DEX tended to increase at 24 h and increased significantly at 48 h. The metabolomic analysis showed that the levels of citrulline, arginine, and ornithine did not differ significantly between Otc(spf−ash) mice that were administered DEX and normal saline; however, the level of aspartate was increased drastically in Otc(spf−ash) mice owing to DEX administration (P < 0.01). Among the enzymes associated with the urea cycle, mRNA expressions of carbamoyl-phosphate synthase 1, ornithine transcarbamylase, arginosuccinate synthase 1, and arginosuccinate lyase in the livers were significantly downregulated by DEX administration in both the Otc(spf−ash) and WT mice (P < 0.01). Among the enzymes associated with catabolism, mRNA expression of Muscle RING-finger protein-1 in the muscles was significantly upregulated in the muscles of WT mice by DEX administration (P < 0.05). CONCLUSIONS: We elucidated that corticosteroid administration induced hyperammonemia in Otc(spf−ash) mice by not only muscle catabolism but also suppressing urea-cycle-related gene expressions. Since the urea cycle intermediate amino acids, such as arginine, might not be effective because of the suppressed expression of urea-cycle-related genes by corticosteroid administration, we should consider an early intervention by renal replacement therapy in cases of UCD patients induced by corticosteroids to avoid brain injuries or fatal outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02213-0.
format Online
Article
Text
id pubmed-8962007
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89620072022-03-30 Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency Imoto, Koji Tanaka, Masatake Goya, Takeshi Aoyagi, Tomomi Takahashi, Motoi Kurokawa, Miho Tashiro, Shigeki Kato, Masaki Kohjima, Motoyuki Ogawa, Yoshihiro BMC Gastroenterol Research BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) is most common among urea cycle disorders (UCDs), defined by defects in enzymes associated with ureagenesis. Corticosteroid administration to UCD patients, including OTCD patients, is suggested to be avoided, as it may induce life-threatening hyperammonemia. The mechanism has been considered nitrogen overload due to the catabolic effect of corticosteroids; however, the pathophysiological process is unclear. METHODS: To elucidate the mechanism of hyperammonemia induced by corticosteroid administration in OTCD patients, we analyzed a mouse model by administering corticosteroids to OTC(spf−ash) mice deficient in the OTC gene. Dexamethasone (DEX; 20 mg/kg) was administered to the OTC(spf−ash) and wild-type (WT) mice at 0 and 24 h, and the serum ammonia concentrations, the levels of the hepatic metabolites, and the gene expressions related with ammonia metabolism in the livers and muscles were analyzed. RESULTS: The ammonia levels in Otc(spf−ash) mice that were administered DEX tended to increase at 24 h and increased significantly at 48 h. The metabolomic analysis showed that the levels of citrulline, arginine, and ornithine did not differ significantly between Otc(spf−ash) mice that were administered DEX and normal saline; however, the level of aspartate was increased drastically in Otc(spf−ash) mice owing to DEX administration (P < 0.01). Among the enzymes associated with the urea cycle, mRNA expressions of carbamoyl-phosphate synthase 1, ornithine transcarbamylase, arginosuccinate synthase 1, and arginosuccinate lyase in the livers were significantly downregulated by DEX administration in both the Otc(spf−ash) and WT mice (P < 0.01). Among the enzymes associated with catabolism, mRNA expression of Muscle RING-finger protein-1 in the muscles was significantly upregulated in the muscles of WT mice by DEX administration (P < 0.05). CONCLUSIONS: We elucidated that corticosteroid administration induced hyperammonemia in Otc(spf−ash) mice by not only muscle catabolism but also suppressing urea-cycle-related gene expressions. Since the urea cycle intermediate amino acids, such as arginine, might not be effective because of the suppressed expression of urea-cycle-related genes by corticosteroid administration, we should consider an early intervention by renal replacement therapy in cases of UCD patients induced by corticosteroids to avoid brain injuries or fatal outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02213-0. BioMed Central 2022-03-28 /pmc/articles/PMC8962007/ /pubmed/35346058 http://dx.doi.org/10.1186/s12876-022-02213-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Imoto, Koji
Tanaka, Masatake
Goya, Takeshi
Aoyagi, Tomomi
Takahashi, Motoi
Kurokawa, Miho
Tashiro, Shigeki
Kato, Masaki
Kohjima, Motoyuki
Ogawa, Yoshihiro
Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
title Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
title_full Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
title_fullStr Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
title_full_unstemmed Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
title_short Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
title_sort corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962007/
https://www.ncbi.nlm.nih.gov/pubmed/35346058
http://dx.doi.org/10.1186/s12876-022-02213-0
work_keys_str_mv AT imotokoji corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT tanakamasatake corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT goyatakeshi corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT aoyagitomomi corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT takahashimotoi corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT kurokawamiho corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT tashiroshigeki corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT katomasaki corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT kohjimamotoyuki corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency
AT ogawayoshihiro corticosteroidsuppressesureacyclerelatedgeneexpressionsinornithinetranscarbamylasedeficiency